ProfileOfResearchers

TÃTULO: Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040) : Subgroup analysis by pattern of disease recurrence Full Text
AUTORES: Harrington, K. J.; Cohen, E. E. W.; Soulieres, D.; Dinis, J.; Licitra, L.; Ahn, M. j.; Soria, A.; Machiels, J. p.; Mach, N.; Mehra, R.; Burtness, B.; Swaby, R. F.; Lin, J.; Ge, J.; Lerman, N.; Le Tourneau, C.;
PUBLICAÇÃO: 2023, FONTE: ORAL ONCOLOGY, VOLUME: 147

INDEXADO EM:

Scopus

WOS

TÃTULO: Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040
AUTORES: Soulieres, D.; Harrington, K. J.; Le Tourneau, C.; Silva, J. D.; Licitra, L. F.; Ahn, M J.; Soria, A.; Machiels, J P.; Mach, N.; Mehra, R.; Burtness, B.; Lin, J.; Lerman, N.; Gumuscu, B.; Cohen, E. E. W.;
PUBLICAÇÃO: 2022, FONTE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, NÚMERO: 7

INDEXADO EM:

WOS

TÃTULO: Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040
AUTORES: Harrington, KJ; Soulieres, D; Le Tourneau, C; Dinis, J; Licitra, LF; Ahn, MJ; Soria, A; Machiels, JPH; Mach, N; Mehra, R; Burtness, B; Ellison, MC; Cheng, JD; Chirovsky, DR; Swaby, RF; Cohen, EEW;
PUBLICAÇÃO: 2021, FONTE: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, VOLUME: 113, NÚMERO: 2

INDEXADO EM:

Scopus

WOS

TÃTULO: Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
AUTORES: Burtness, B; Haddad, R; Dinis, J; Trigo, J; Yokota, T; De Souza Viana, L; Romanov, I; Vermorken, J; Bourhis, J; Tahara, M; Martins Segalla, JG; Psyrri, A; Vasilevskaya, I; Nangia, CS; Chaves Conde, M; Kiyota, N; Homma, A; Holeckova, P; Del Campo, JM; Asarawala, N; Nicolau, UR; Rauch, D; Even, C; Wang, B; Gibson, N; Ehrnrooth, E; Harrington, K; Cohen, EEW; ...Mais
PUBLICAÇÃO: 2019, FONTE: JAMA ONCOLOGY, VOLUME: 5, NÚMERO: 8

INDEXADO EM:

Scopus

WOS

TÃTULO: Pembrolizumab (pembro) for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of phase 3 KEYNOTE-040 prior radiation treatment (RT) and disease state.
AUTORES: Kevin J Harrington; Ezra E W Cohen; Denis Soulieres; Jose Dinis; Lisa F Licitra; Myung Ju Ahn; Ainara Soria; Jean Pascal H Machiels; Nicolas Mach; Ranee Mehra; Barbara Burtness; Jianxin X Lin; Jonathan D Cheng; Ramona F Swaby; Christophe Le Tourneau;
PUBLICAÇÃO: 2019, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, NÚMERO: 15

INDEXADO EM:

WOS

TÃTULO: Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial
AUTORES: Le Tourneau, C; Cohen, EEW; Harrington, KJ; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulieres, D;
PUBLICAÇÃO: 2018, FONTE: 43rd ESMO Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 29

INDEXADO EM:

WOS

TÃTULO: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma
AUTORES: Denis Soulieres; Ezra Cohen; Christophe Le Tourneau; Jose Dinis; Lisa Licitra; Myung Ju Ahn; Ainara Soria; Jean Pascal Machiels; Nicolas Mach; Ranee Mehra; Barbara Burtness; Pingye Y Zhang; Jonathan Cheng; Ramona Swaby; Kevin J Harrington;
PUBLICAÇÃO: 2018, FONTE: Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 78, NÚMERO: 13

INDEXADO EM:

WOS

TÃTULO: Pembrolizumab for recurrent head and neck squamous cell carcinoma (HNSCC): Post hoc analyses of treatment options from the phase III KEYNOTE-040 trial
AUTORES: Le Tourneau, C; Cohen, EEW; Harrington, KJ; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Zhang, P; Cheng, J; Swaby, R; Soulières, D;
PUBLICAÇÃO: 2018, FONTE: Annals of oncology : official journal of the European Society for Medical Oncology, VOLUME: 29

INDEXADO EM:

Scopus

TÃTULO: Pembrolizumab (pembro) vs standard of care (SOC) for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC): Phase 3 KEYNOTE-040 trial
AUTORES: Cohen, EE; Harrington, KJ; Le Tourneau, C; Dinis, J; Licitra, L; Ahn, MJ; Soria, A; Machiels, JP; Mach, N; Mehra, R; Burtness, B; Wang, Y; Tuozzo, AJ; Swaby, R; Soulieres, D;
PUBLICAÇÃO: 2017, FONTE: 42nd European-Society-for-Medical-Oncology Congress (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 28

INDEXADO EM:

WOS

INDEXADO EM:

Scopus

WOS

Página 1 de 2. Total de resultados: 11.

Links Úteis